Abstract
Objective To explore the correlation or potential causation between mental disorders [depression, schizophrenia (SCZ), bipolar disorder (BIP)], and abdominal aortic aneurysm (AAA).
Methods Summary-level genetic data sets were obtained from the large-scale genome-wide association studies. We first investigated the genetic correlation between AAA and mental disorders from the perspectives of global/local genetic correlation and shared genomic loci. Following that, the bidirectional univariable Mendelian Randomization (UMR) was conducted to assess their causal relationship, with multivariable MR (MVMR) to control the effect from confounders. Finally, the mediation analyses were performed to evaluate whether the causality was mediated by the known risk factors, e.g., smoking, and hypertension.
Results Global genetic correlation analyses presented that depression and SCZ were correlated with AAA, while BIP was not. Besides, AAA was found to be locally correlated with depression, SCZ, and BIP in 4, 7, and 10 genomic regions, respectively. Additionally, a total of 26, 141, and 10 shared genomic loci were respectively found between AAA and depression, SCZ, and BIP. The UMR analyses indicated genetically predicted depression (OR: 1.270, 95% CI: 1.071-1.504, p = 0.006) and SCZ (OR: 1.047, 95% CI: 1.010-1.084, p = 0.011) were associated with an elevated risk of AAA, while no causal effects of BIP on AAA, and AAA on three mental disorders were found. These associations were consistently robust in MVMR analyses. The mediation analyses indicated the causal effect of depression on AAA was mediated by smoking, hypertension, hyperlipidemia, as well as coronary atherosclerosis, and smoking mediated the effect of SCZ on AAA.
Conclusion Genetically predicted depression and SCZ were associated with elevated risk of AAA, and the known risk factors of AAA playing the mediation roles.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study received no external funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The datasets used in this study were all publicly available from previous studies, and the ethical approvals were obtained by the original researchers. Therefore, the ethical approval for this study could be waived.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The datasets utilized in this study are publicly available and the details could be found in supplementary method.
